SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Kyndryl Holdings, Inc. is a technology services company, which engages in the provision of infrastructure services. It operates through the following segments: United States, Japan, Principal Markets, and Strategic Markets. The Principal Markets segment represents the aggregation of operations in Australia, New Zealand, Canada, France, Germany, India, Italy, Spain, Portugal, the United Kingdom, and Ireland. The company was founded on December 4, 2020 and is headquartered in New York, NY.

Kyndryl Holdings Inc

Kyndryl (KD) plunged after its CFO and general counsel exited amidst an SEC investigation and accounting review uncovering internal control weaknesses, leading to a fierce debate among investors questioning potential fraud versus an extreme, oversold market reaction.

Pagaya Technologies Ltd. engages in the development of AI and data networks for the financial industry. Its product deploys data science, machine learning and AI technology to evaluate the customers' applications in real time. The company was founded by Gal Krubiner, Sanjiv Das, Yahav Yulzari, and Avital Pardo on March 20, 2016 and is headquartered in New York, NY.

Pagaya Technologies Ltd - Ordinary Shares - Class A

Pagaya Technologies Ltd

Pagaya Technologies is seeing heavy discussion and a sharp sell-off following its recent earnings, which delivered mixed results and conservative guidance that many in the community view as an extreme overreaction given the company's profitability and AI-powered model. This severe market reaction, fueled by broader negative sentiment impacting the fintech sector, has sparked intense debate between those accumulating at what they see as deeply undervalued levels and others frustrated by alleged market manipulation.

REGENXBIO, Inc. is a clinical-stage biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. Its product candidates include the NAV Technology Platform, which consists of exclusive rights to novel adeno-associated viral vectors, and therapeutic programs such as RGX-314, RGX-202, RGX-121, RGX-111, RGX-181, and RGX-381. The company was founded by Kenneth T. Mills and James M. Wilson on July 16, 2008 and is headquartered in Rockville, MD.

Regenxbio Inc

REGENXBIO is trending as the FDA issued a Complete Response Letter for its RGX-121 gene therapy for Hunter syndrome, citing concerns with trial design and the use of natural history controls. This decision has sparked widespread community discussion regarding the financial outlook for RGNX and the potential impact on its other gene therapy candidates, which utilize similar trial methodologies.

Ichor Holdings Ltd. engages in designing, engineering, and manufacturing fluid delivery subsystems for semiconductor capital equipment. It offers gas and chemical delivery systems, which are key elements of the process tools used in the manufacturing of semiconductor devices. The firm also manufactures precision machined components, weldments, and proprietary products for use in fluid delivery systems for direct sales to its customers. The company was founded in 1999 and is headquartered in Fremont, CA.

Ichor Holdings Ltd

Ichor Holdings is experiencing a notable after-hours surge following a strong earnings report that surpassed expectations and provided an optimistic outlook. Community sentiment is highly bullish, fueled by both the positive financial results and speculative interest from reported political insider buying, emphasizing ICHR's role in the semiconductor capital equipment sector amidst a focus on domestic chip manufacturing.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

Advanced Micro Devices is experiencing a strong "buy the dip" sentiment following a post-earnings sell-off, driven by analyst upgrades and reports of its server CPU capacity being largely sold out due to immense hyperscale data center demand. The community is highly bullish, viewing this as an inflection point for the semiconductor giant as it is poised for significant market share gains in the accelerating AI infrastructure buildout.

GALA is designed to power the Gala Games ecosystem to support gaming re-imagined to benefit creators and players, alike.

Gala Games

Gala Games (GALA) is generating buzz due to new ecosystem developments, including strategic partnerships for NFT gaming in China and expanded multi-chain integrations, fueling optimism for its Web3 entertainment platform. However, the community remains sharply divided, with ongoing debates concerning its long-term potential versus past performance and perceived token distribution pressures.

Bankr is an advanced AI agent focused on simplifying the process of buying and selling digital assets. Bankr was the first AI agent on Farcaster to help you quickly buy all your favorites coins directly in the social. BankrCoin is the official coin of the agent and was deployed by Bankr itself directly in the Farcaster social feed. Fees from swaps go to support BankrCoin. Bankr is available on Farcaster and will soon be launching a private terminal, token recs, and limit orders on Base.

BankrCoin

BNKR is experiencing significant upward momentum, driven by community excitement around breaking key price barriers, recent exchange listings, and its expanding AI agent utility within the Base and Solana ecosystems.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is trending ahead of its Q4 earnings report, with community discussion focused on its strategic hyperscaler contracts and full-stack AI infrastructure positioning amid an industry-wide surge in AI spending. Bullish investors are anticipating strong results and long-term growth, while some express caution regarding potential market volatility and profitability concerns.

The Boeing Co. is an aerospace company, which engages in the manufacture of commercial jetliners and defense, space, and security systems. It operates through the following segments: Commercial Airplanes (BCA), Defense, Space and Security (BDS), and Global Services (BGS). The Commercial Airplanes segment includes the development, production, and market of commercial jet aircraft and provides fleet support services, principally to the commercial airline industry worldwide. The Defense, Space and Security segment refers to the research, development, production and modification of manned and unmanned military aircraft and weapons systems for global strike, including fighter and combat rotorcraft aircraft and missile systems, global mobility, including tanker, rotorcraft and tilt-rotor aircraft, and airborne surveillance and reconnaissance, including command and control, battle management and airborne anti-submarine aircraft. The Global Services segment provides services to commercial and defense customers. The company was founded by William Edward Boeing on July 15, 1916, and is headquartered in Arlington, VA.

Boeing Co.

Boeing Co

Boeing is drawing significant market attention as it reports strong earnings with increased deliveries and positive cash flow, buoyed by major new aircraft orders from India, while investors closely monitor its production ramp-up and ongoing regulatory certifications.

Firefly Aerospace, Inc. engages in the design and manufacture of space launch vehicles. It offers Alpha, Beta, Gamma, and orbital transfer vehicles. The company was founded by Thomas E. Markusic, Mark Watt, and Max Polyakov in January 27, 2017 and is headquartered in Cedar Park, TX.

Firefly Aerospace Inc.

Firefly Aerospace is trending as the community anticipates its Alpha rocket launch and weighs its recent inclusion in the Russell indexes and a major SHIELD defense contract. Investors are actively debating its valuation and volatility, with broader sector excitement driven by the impending SpaceX IPO.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Ocular Therapeutix (NASDAQ:OCUL) Raised to Hold at Wall Street Zen

Wall Street Zen upgraded Ocular Therapeutix from a "sell" rating to a "hold" rating in a report on Saturday...

Ocular Therapeutix (NASDAQ:OCUL) Shares Up 8.8% on Better-Than-Expected Earnings

Ocular Therapeutix (NASDAQ:OCUL) Trading Up 8.8% After Strong Earnings...

Donald Notman Sells 5,455 Shares of Ocular Therapeutix (NASDAQ:OCUL) Stock

Ocular Therapeutix, Inc. (NASDAQ:OCUL - Get Free Report) COO Donald Notman sold 5,455 shares of the stock in a transaction dated Monday, February 2nd. The stock was sold at an average price of $9.14...

Ocular Therapeutix (OCUL) Reports Q4 Loss, Misses Revenue Estimates

Ocular Therapeutix (OCUL) delivered earnings and revenue surprises of +12.65% and -12.22%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Ocular Therapeutix (NASDAQ:OCUL) Share Price Crosses Below 200-Day Moving Average - Here's Why

Ocular Therapeutix (NASDAQ:OCUL) Shares Cross Below Two Hundred Day Moving Average - What's Next...

RSI Alert: Ocular Therapeutix (OCUL) Now Oversold

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a...

Ocular Therapeutix (NASDAQ:OCUL) Shares Down 5.9% - What's Next?

Ocular Therapeutix (NASDAQ:OCUL) Shares Down 5.9% - What's Next...

Ocular Therapeutix Sees Unusually Large Options Volume (NASDAQ:OCUL)

Ocular Therapeutix, Inc. (NASDAQ:OCUL - Get Free Report) was the target of unusually large options trading on Friday. Stock traders acquired 11,873 put options on the stock. This represents an...

Ocular Therapeutix (NASDAQ:OCUL) Shares Gap Up - Time to Buy?

Ocular Therapeutix (NASDAQ:OCUL) Shares Gap Up - What's Next...

Ocular Therapeutix Target of Unusually High Options Trading (NASDAQ:OCUL)

Ocular Therapeutix, Inc. (NASDAQ:OCUL - Get Free Report) was the target of unusually large options trading on Thursday. Stock traders purchased 3,324 call options on the stock. This represents an...

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

What do you expect from $HOOD earnings on Tuesday?

OCUL
Ocular Therapeutix Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest OCUL News

OCULOcular Therapeutix Inc